Correction to: Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents—a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group

被引：0

作者：

Esther Schuler

Eva-Maria Wagner-Drouet

Salem Ajib

Gesine Bug

Martina Crysandt

Sabine Dressler

Andreas Hausmann

Daniela Heidenreich

Klaus Hirschbühl

Matthias Hoepting

Edgar Jost

Jennifer Kaivers

Stefan Klein

Michael Koldehoff

Lambros Kordelas

Oliver Kriege

Lutz P. Müller

Christina Rautenberg

Judith Schaffrath

Christoph Schmid

Daniel Wolff

Rainer Haas

Martin Bornhäuser

Thomas Schroeder

Guido Kobbe

机构：

[1] Heinrich Heine University,Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Medical Faculty

[2] UCT Johannes Gutenberg-University Mainz,Department of Hematology, Oncology, Pneumology, Medical Clinic III

[3] Goethe University,Department of Medicine II

[4] University Hospital RWTH Aachen,Department of Hematology, Oncology, Hemostasiology and Stem Cell Transplantation, Medical Clinic IV

[5] Bone Marrow Transplantation Unit,Medical Clinic III

[6] Medical Clinic 5,Department of Hematology and Oncology, Medical Clinic II

[7] Department of Hematology,Medical Clinic III

[8] Oncology,Clinic for Bone Marrow Transplantation

[9] Immunology,Department of Internal Medicine IV, University Hospital Halle

[10] Palliative Care,Department of Internal Medicine I

[11] Munich Clinic Schwabing,undefined

[12] University Medicine Mannheim,undefined

[13] University Hospital Augsburg,undefined

[14] University Medicine Regensburg,undefined

[15] University Hospital Essen,undefined

[16] Martin-Luther-University Halle-Wittenberg,undefined

[17] University Hospital Carl Gustav Carus at the Technische Universität,undefined

来源：

Annals of Hematology | 2021年 / 100卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

A Correction to this paper has been published: https://doi.org/10.1007/s00277-021-04564-2

引用

页码：2141 / 2142

页数：1

共 50 条

[1] Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents—a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group
Esther Schuler
Eva-Maria Wagner-Drouet
Salem Ajib
Gesine Bug
Martina Crysandt
Sabine Dressler
Andreas Hausmann
Daniela Heidenreich
Klaus Hirschbühl
Matthias Hoepting
Edgar Jost
Jennifer Kaivers
Stefan Klein
Michael Koldehoff
Lambros Kordelas
Oliver Kriege
Lutz P. Müller
Christina Rautenberg
Judith Schaffrath
Christoph Schmid
Daniel Wolff
Rainer Haas
Martin Bornhäuser
Thomas Schroeder
Guido Kobbe
Annals of Hematology, 2021, 100 : 959 - 968
[2] Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents-a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group
Schuler, Esther
Wagner-Drouet, Eva-Maria
Ajib, Salem
Bug, Gesine
Crysandt, Martina
Dressler, Sabine
Hausmann, Andreas
Heidenreich, Daniela
Hirschbuehl, Klaus
Hoepting, Matthias
Jost, Edgar
Kaivers, Jennifer
Klein, Stefan
Koldehoff, Michael
Kordelas, Lambros
Kriege, Oliver
Mueller, Lutz P.
Rautenberg, Christina
Schaffrath, Judith
Schmid, Christoph
Wolff, Daniel
Haas, Rainer
Bornhaeuser, Martin
Schroeder, Thomas
Kobbe, Guido
ANNALS OF HEMATOLOGY, 2021, 100 (04) : 959 - 968
[3] Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents-a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group (vol 100, pg 959, 2021)
Schuler, Esther
Wagner-Drouet, Eva-Maria
Ajib, Salem
Bug, Gesine
Crysandt, Martina
Dressler, Sabine
Hausmann, Andreas
Heidenreich, Daniela
Hirschbuhl, Klaus
Hoepting, Matthias
Jost, Edgar
Kaivers, Jennifer
Klein, Stefan
Koldehoff, Michael
Kordelas, Lambros
Kriege, Oliver
Mueller, Lutz P.
Rautenberg, Christina
Schaffrath, Judith
Schmid, Christoph
Wolff, Daniel
Haas, Rainer
Bornhaeuser, Martin
Schroeder, Thomas
Kobbe, Guido
ANNALS OF HEMATOLOGY, 2021, 100 (08) : 2141 - 2142
[4] Venetoclax plus hypomethylating agent for the salvage treatment of relapsing myeloid malignancies after hematopoietic stem cell transplantation: A multicenter retrospective study on behalf of the Zhejiang Cooperative Group for Blood and Marrow Transplantation
Gao, Fei
Gao, Yang
Luo, Yi
Yu, Jian
Fu, Huarui
Lai, Xiaoyu
Liu, Lizhen
Ye, Baodong
Lan, Jianping
Song, Xiaolu
Lu, Ying
Chen, Lieguang
Chen, Yi
Yu, Kang
Huang, He
Shi, Jimin
Zhao, Yanmin
AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (02) : E44 - E47
[5] Venetoclax Plus Hypomethylating Agent for the Salvage Treatment of Myeloid Malignancies Relapsing after Hematopoietic Stem Cell Transplantation: A Multicenter Retrospective Study on Behalf of the Zhejiang Cooperative Group for Blood and Marrow Transplantation
Gao, Fei
Luo, Yi
Yu, Jian
Fu, Huarui
Lai, Xiaoyu
Liu, Lizhen
Ye, Baodong
Lan, Jianping
Song, Xiaolu
Lu, Ying
Chen, Lieguang
Chen, Yi
Yu, Kang
Huang, He
Shi, Jimin
Zhao, Yanmin
BLOOD, 2021, 138 : 1825 - +
[6] Venetoclax, Hypomethylating Agents and Dli for Salvage Treatment of Myeloid Malignancies Relapsing after Allogeneic Hematopoietic Stem Cell Transplantation
Schuler, Esther
Wagner-Drouet, Eva-Maria
Ajib, Salem
Bug, Gesine
Crysandt, Martina
Dressler, Sabine
Hausmann, Andreas
Heidenreich, Daniela
Hirschbuehl, Klaus
Hoepting, Matthias
Jost, Edgar
Kaivers, Jennifer
Klein, Stefan
Kordelas, Lambros
Kriege, Oliver
Mueller, Lutz
Rautenberg, Christina
Schaffrath, Judith
Schmid, Christoph
Wolff, Daniel
Haas, Rainer
Bornhaeuser, Martin
Schroeder, Thomas
Kobbe, Guido
BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 590 - 591
[7] Treatment of relapsed AML and MDS after allogeneic stem cell transplantation with decitabine and DLI—a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group
Thomas Schroeder
Christina Rautenberg
William Krüger
Uwe Platzbecker
Gesine Bug
Juliane Steinmann
Stefan Klein
Olaf Hopfer
Kathrin Nachtkamp
Mustafa Kondakci
Stefanie Geyh
Rainer Haas
Ulrich Germing
Martin Bornhäuser
Guido Kobbe
Annals of Hematology, 2018, 97 : 335 - 342
[8] Use of venetoclax in combination with hypomethylating agents in patients with acute myeloid leukemia relapsing after allogeneic hematopoietic stem cell transplantation
Ozturk, C.
Sahin, U.
Seval, G. C.
Bozdag, S. C.
Toprak, S. K.
Yuksel, M. K.
Topcuoglu, P.
Ozcan, M.
Gurman, G.
Ilhan, O.
Arslan, O.
BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 335 - 336
[9] Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation with Venetoclax, Hypomethylating Agents and DLI - a Retrospective Multi Center Study
Schuler, Esther
Wagner-Drouet, Eva-Maria
Ajib, Salem
Bug, Gesine
Crysandt, Martina
Dressler, Sabine
Hausmann, Andreas
Heidenreich, Daniela
Hirschbuhl, Klaus
Hoepting, Matthias
Jost, Edgar
Kaivers, Jennifer
Klein, Stefan A.
Kordelas, Lambros
Kriege, Oliver
Mueller, Lutz Peter
Rautenberg, Christina
Schaffrath, Judith
Schmid, Christoph
Wolff, Daniel
Bornhaeuser, Martin
Schroeder, Thomas
Kobbe, Guido
BLOOD, 2019, 134
[10] Treatment of relapsed AML and MDS after allogeneic stem cell transplantation with decitabine and DLI-a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group
Schroeder, Thomas
Rautenberg, Christina
Krueger, William
Platzbecker, Uwe
Bug, Gesine
Steinmann, Juliane
Klein, Stefan
Hopfer, Olaf
Nachtkamp, Kathrin
Kondakci, Mustafa
Geyh, Stefanie
Haas, Rainer
Germing, Ulrich
Bornhaeuser, Martin
Kobbe, Guido
ANNALS OF HEMATOLOGY, 2018, 97 (02) : 335 - 342

← 1 2 3 4 5 →